Stephen R. Davis

Chief Executive Officer

Serge Stankovic, M.D., M.S.P.H.

President

Austin D. Kim

Executive Vice President,
General Counsel and Secretary

Mark Schneyer

Executive Vice President, Chief Financial Officer

Brendan Teehan

Executive Vice President, Chief Operating Officer, Head of Commercial

Rob Ackles

Senior Vice President, Chief People Officer

Kathie M. Bishop, Ph.D.

Senior Vice President, Chief Scientific Officer and Head of Rare Disease

Daryl DeKarske

Senior Vice President, Global Head of Regulatory Affairs and Head of Translational Sciences

Julie Fisher

Senior Vice President, Marketing and Commercial Strategy

Bob Mischler

Senior Vice President, Strategy and Technology Operations

Parag Meswani, Pharm.D.

Senior Vice President, Trofinetide – Rare Disease Franchise

Sanjeev Pathak, M.D.

Senior Vice President, Head of Clinical Development

Ponni Subbiah, M.D., M.P.H.

Senior Vice President, Global Head of Medical Affairs and Chief Medical Officer

Mary Ellen Turner, M.D., M.P.H.

Senior Vice President, Pharmacovigilance and Corporate Safety Officer

Holly Valdiviez

Senior Vice President, Head of Sales